Simon Sjodin

Goeteborg, O, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Calcium modulating ligand confers risk for Parkinson's disease and impacts lysosomes.

Calcium modulating ligand confers risk for Parkinson's disease and impacts lysosomes.

Journal: Annals of clinical and translational neurology

Published: December 02, 2024

Differential patterns of lysosomal dysfunction are seen in the clinicopathological forms of primary progressive aphasia.

Differential patterns of lysosomal dysfunction are seen in the clinicopathological forms of primary progressive aphasia.

Journal: Journal of neurology

Published: August 15, 2023

Endo-lysosomal protein concentrations in CSF from patients with frontotemporal dementia caused by CHMP2B mutation.

Endo-lysosomal protein concentrations in CSF from patients with frontotemporal dementia caused by CHMP2B mutation.

Journal: Alzheimer's & dementia (Amsterdam, Netherlands)

Published: September 01, 2022

Cerebrospinal fluid amyloid precursor protein as a potential biomarker of fatigue in multiple sclerosis: A pilot study.

Cerebrospinal fluid amyloid precursor protein as a potential biomarker of fatigue in multiple sclerosis: A pilot study.

Journal: Multiple sclerosis and related disorders

Published: October 28, 2021

Association between CSF alpha-synuclein seeding activity and genetic status in Parkinson's disease and dementia with Lewy bodies.

Association between CSF alpha-synuclein seeding activity and genetic status in Parkinson's disease and dementia with Lewy bodies.

Journal: Acta neuropathologica communications

Published: September 14, 2021

CSF Protein Level of Neurotransmitter Secretion, Synaptic Plasticity, and Autophagy in PD and DLB.

CSF Protein Level of Neurotransmitter Secretion, Synaptic Plasticity, and Autophagy in PD and DLB.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: March 18, 2021

Cerebrospinal fluid biomarker panel for synaptic dysfunction in Alzheimer's disease.

Cerebrospinal fluid biomarker panel for synaptic dysfunction in Alzheimer's disease.

Journal: Alzheimer's & dementia (Amsterdam, Netherlands)

Published: January 14, 2021

Cerebrospinal fluid endo-lysosomal proteins as potential biomarkers for Huntington's disease.

Cerebrospinal fluid endo-lysosomal proteins as potential biomarkers for Huntington's disease.

Journal: PloS one

Published: May 12, 2020

Quantification of total apolipoprotein E and its isoforms in cerebrospinal fluid from patients with neurodegenerative diseases.

Quantification of total apolipoprotein E and its isoforms in cerebrospinal fluid from patients with neurodegenerative diseases.

Journal: Alzheimer's research & therapy

Published: December 06, 2019

Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer's and Parkinson's disease.

Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer's and Parkinson's disease.

Journal: Alzheimer's research & therapy

Published: June 20, 2019

A Parallel Reaction Monitoring Mass Spectrometric Method for Analysis of Potential CSF Biomarkers for Alzheimer's Disease.

A Parallel Reaction Monitoring Mass Spectrometric Method for Analysis of Potential CSF Biomarkers for Alzheimer's Disease.

Journal: Proteomics. Clinical applications

Published: September 08, 2017

Mass Spectrometric Analysis of Cerebrospinal Fluid Ubiquitin in Alzheimer's Disease and Parkinsonian Disorders.

Mass Spectrometric Analysis of Cerebrospinal Fluid Ubiquitin in Alzheimer's Disease and Parkinsonian Disorders.

Journal: Proteomics. Clinical applications

Published: June 30, 2017

Showing 1-12 of 14

Last Updated: 09/26/2026